chr11-62602481-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153265.3(EML3):c.2685C>A(p.Asp895Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000683 in 1,536,534 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153265.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EML3 | NM_153265.3 | c.2685C>A | p.Asp895Glu | missense_variant | 22/22 | ENST00000394773.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EML3 | ENST00000394773.7 | c.2685C>A | p.Asp895Glu | missense_variant | 22/22 | 1 | NM_153265.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152180Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000797 AC: 11AN: 138056Hom.: 0 AF XY: 0.0000536 AC XY: 4AN XY: 74652
GnomAD4 exome AF: 0.0000376 AC: 52AN: 1384354Hom.: 0 Cov.: 39 AF XY: 0.0000337 AC XY: 23AN XY: 681924
GnomAD4 genome AF: 0.000348 AC: 53AN: 152180Hom.: 1 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 15, 2024 | The c.2685C>A (p.D895E) alteration is located in exon 22 (coding exon 22) of the EML3 gene. This alteration results from a C to A substitution at nucleotide position 2685, causing the aspartic acid (D) at amino acid position 895 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at